BARDA's RRPV - Request for Information - Central Influenza Virus and Emerging Infectious Disease Immunogenicity Laboratory Services

The purpose of this posting is to provide notice of a Request for Information (RFI) and to make interested parties aware of an upcoming Industry Day on April 16th, 2024 to inform a potential new Request for Project Proposal (RPP) under the Biomedical Advanced Research and Development Authority's (BARDA) Rapid Response Partnership Vehicle (RRPV) for the Central Influenza Virus and Emerging Infectious Disease Immunogenicity Laboratory Services.

BARDA is interested in learning more about the requested laboratory services that will support advanced research and development of influenza virus vaccines and emerging infectious diseases vaccines, including support for Phase 1, 2, and 3 clinical trial endpoints.

To view the full RFI, including the specific questions for which BARDA is seeking answers, as well as to access further information about attending the upcoming Industry Day, please view the "RFI - Central Influenza and Emerging Infectious Diseases Vaccine Immunogenicity Laboratory Services" posting via the RRPV website at https://www.rrpv.org/solicitation/request-for-information/rfi-central_flu_lab/.